Medicare just scored some serious wins in its latest drug price negotiations. Fifteen drugs will see price drops, with some discounts reaching as high as 85%. This is huge for the over 50 million seniors who rely on Medicare. The biggest winners? Drugs like Ozempic, Wegovy, and Rybelsus, which treat obesity and Type 2 diabetes. These drugs will see a massive 71% pri...
In Canada, a recent study took a closer look at the people who treat cancer with radiation. It's called radiation oncologists. They wanted to see how diverse this group is. They also wanted to know if these doctors face unfair treatment at work. The study asked about many things. It asked about gender, sexual orientation, and disability. It also asked about race, re...
Healthcare workers face tough challenges. They deal with science and emotions every day. But when kids are very sick, things get even harder. Many professionals turn to faith for strength. They find comfort in spirituality. This helps them care for their young patients. Not all doctors and nurses are religious. Some believe in science only. Others mix faith with the...
The Trump administration has struck deals with drug companies to lower Medicare prices for 15 medications. These deals are part of a program that started under President Biden. The goal is to save money for both taxpayers and seniors. However, the actual savings for individuals will vary based on their specific Medicare plans and prescription costs. The drugs involv...
The GOP is facing a wave of departures, and it's not just about one person. Marjorie Taylor Greene's exit is just the tip of the iceberg. With 22 House Republicans already saying they won't run again, the party's future looks uncertain. This isn't normal; analysts say this is more than usual. Greene, a fiery representative from Georgia, stepped down after a public f...
Repligen Corporation, a key player in the life sciences field, is all set to shine at the 8th Annual Evercore Healthcare Conference. This event, taking place in sunny Coral Gables, Florida, from December 2nd to 4th, is a big deal for the industry. Jason Garland, the company's Chief Financial Officer, will be in the spotlight on December 3rd at 1:20 p. m. ET. He'll be...
In the fast-paced world of biotech, making decisions can feel like navigating a battlefield. David Esposito, a seasoned leader in this field, knows this all too well. His background as an infantry officer in the U. S. Army's 101st Airborne Division has shaped his approach to leadership. He believes that in times of uncertainty, a leader must step up and make tough ca...
UnitedHealthcare's plan to limit remote patient monitoring (RPM) reimbursement starting in 2026 is a big mistake. They will only cover heart failure and hypertensive disorders during pregnancy. This decision ignores the growing evidence that RPM helps manage common conditions like hypertension and diabetes. It also goes against the trend of modernizing chronic care. ...
The recent MAHA Summit in Washington, D. C. , brought together a diverse group of people, including big tech and pharma companies, government officials, and grassroots supporters. The event aimed to accelerate the adoption of the MAHA agenda, which focuses on improving health and wellness in America. However, the inclusion of big tech and pharma companies sparked mix...
In Ontario, Canada, a concerning trend has been observed with carbapenemase-producing Enterobacter (CP-Ent) bacteria. These superbugs are becoming more common. They are the third most prevalent type of carbapenemase-producing Enterobacteriaceae globally. What makes them particularly troublesome is their high strain diversity. Researchers looked into the spread of CP...